K6 STRATEGIES, LLC for CHRYSALIS BIOTHERAPEUTICS, INC.
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Advocacy and lobbying to the relevant committees who have oversight for Defense, DHS, public health, energy, cience and pharmaceuticals to educate them about drug treatment being developed by Chrysalis Bio Therapeutics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEAN MARIE KRANZ New | Senior Advisor/Staff, Congressman Pete Olson (TX-22) |
Disaster Planning/Emergencies DIS
Advocacy and lobbying to the relevant committees who have oversight for Defense, DHS, public health, energy, cience and pharmaceuticals to educate them about drug treatment being developed by Chrysalis Bio Therapeutics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEAN MARIE KRANZ New | Senior Advisor/Staff, Congressman Pete Olson (TX-22) |
Government Issues GOV
Advocacy and lobbying to the relevant committees who have oversight for Defense, DHS, public health, energy, cience and pharmaceuticals to educate them about drug treatment being developed by Chrysalis Bio Therapeutics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEAN MARIE KRANZ New | Senior Advisor/Staff, Congressman Pete Olson (TX-22) |
Homeland Security HOM
Advocacy and lobbying to the relevant committees who have oversight for Defense, DHS, public health, energy, cience and pharmaceuticals to educate them about drug treatment being developed by Chrysalis Bio Therapeutics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEAN MARIE KRANZ New | Senior Advisor/Staff, Congressman Pete Olson (TX-22) |
Budget/Appropriations BUD
Advocacy and lobbying to the relevant committees who have oversight for Defense, DHS, public health, energy, cience and pharmaceuticals to educate them about drug treatment being developed by Chrysalis Bio Therapeutics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEAN MARIE KRANZ New | Senior Advisor/Staff, Congressman Pete Olson (TX-22) |
Defense DEF
Advocacy and lobbying to the relevant committees who have oversight for Defense, DHS, public health, energy, cience and pharmaceuticals to educate them about drug treatment being developed by Chrysalis Bio Therapeutics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEAN MARIE KRANZ New | Senior Advisor/Staff, Congressman Pete Olson (TX-22) |
Pharmacy PHA
Advocacy and lobbying to the relevant committees who have oversight for Defense, DHS, public health, energy, cience and pharmaceuticals to educate them about drug treatment being developed by Chrysalis Bio Therapeutics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEAN MARIE KRANZ New | Senior Advisor/Staff, Congressman Pete Olson (TX-22) |
Science/Technology SCI
Advocacy and lobbying to the relevant committees who have oversight for Defense, DHS, public health, energy, cience and pharmaceuticals to educate them about drug treatment being developed by Chrysalis Bio Therapeutics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEAN MARIE KRANZ New | Senior Advisor/Staff, Congressman Pete Olson (TX-22) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.